Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines.

Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines.
复制标题

DOI:
10.1038/srep37849
复制
发表时间:
2016-11-28
期刊:
影响因子:
4.6
通讯作者:
Harashima H
Harashima H
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Nakamura T;Kuroi M;Fujiwara Y;Warashina S;Sato Y;Harashima H

文献摘要

参考文献

被引文献

相似文献

小干扰 RNA (siRNA) 的基因沉默可用于分析人类免疫细胞的功能。然而,将siRNA转染至人体免疫细胞是很困难的。在这里,我们使用含有 YSK12-C4 (YSK12-MEND) 的多功能包膜型纳米器件 (MEND) 将 siRNA 有效引入人类免疫细胞系 Jurkat、THP-1、KG-1 和 NK92。将 YSK12-MEND 以 1-30nM 的 siRNA 剂量转染至人免疫细胞系中,Jurkat、THP-1、KG-1 和 NK92 中 mRNA 水平的最大基因沉默效率分别为 96%、96%、91% 和 75%。 Lipofectamine RNAiMAX (RNAiMAX) 的相应值分别为 37%、56%、43% 和 19%。与细胞摄取相关的过程在YSK12-MEND的有效基因沉默作用中发挥了作用。 YSK12-MEND 的小尺寸和高非聚集性有利于 siRNA 向免疫细胞系的细胞内化。在 RNAiMAX 的情况下,在所用的培养基中观察到颗粒尺寸急剧增加,这抑制了细胞的摄取。本文报道的YSK12-MEND似乎适合将siRNA递送至人类免疫细胞,并且小粒径和不可聚集性是基本特性。
Gene silencing by small interfering RNA (siRNA) is useful for analyzing the functions of human immune cells. However, the transfection of siRNA to human immune cells is difficult. Here, we used a multifunctional envelope-type nanodevice (MEND) containing YSK12-C4 (YSK12-MEND) to efficiently introduce siRNA to human immune cell lines, Jurkat, THP-1, KG-1 and NK92. The YSK12-MEND was transfected to human immune cell lines at a siRNA dose range of 1–30 nM, resulting that maximum gene silencing efficiencies at the mRNA level in Jurkat, THP-1, KG-1 and NK92 were 96%, 96%, 91% and 75%, respectively. The corresponding values for Lipofectamine RNAiMAX (RNAiMAX) were 37%, 56%, 43% and 19%, respectively. The process associated with cellular uptake played a role in effective gene silencing effect of the YSK12-MEND. The small size and high non-aggregability of the YSK12-MEND were advantageous for the cellular internalization of siRNA to immune cell lines. In the case of RNAiMAX, a drastic increase in particles size was observed in the medium used, which inhibited cellular uptake. The YSK12-MEND reported in herein appears to be appropriate for delivering siRNA to human immune cells, and the small particle size and non-aggregability are essential properties.
DOI: 10.3389/fimmu.2016.00091
发表时间: 2016
影响因子: 7.3
作者:
Klingemann H;Boissel L;Toneguzzo F
通讯作者: Toneguzzo F
DOI: 10.1073/pnas.0807883106
发表时间: 2009-04-14
影响因子: 11.1
作者:
McNaughton, Brian R.;Cronican, James J.;Liu, David R.
通讯作者: Liu, David R.
DOI: 10.4049/jimmunol.1103627
发表时间: 2012-04-15
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者:
Lozano E;Dominguez-Villar M;Kuchroo V;Hafler DA
通讯作者: Hafler DA
DOI: 10.1038/nri3071
发表时间: 2011-10-10
期刊: Nature reviews. Immunology
影响因子: --
作者:
通讯作者: --
DOI: 10.1038/mt.2012.209
发表时间: 2013-01-01
期刊: MOLECULAR THERAPY
影响因子: 12.4
作者:
Tezgel, A. Oezguel;Gonzalez-Perez, Gabriela;Tew, Gregory N.
通讯作者: Tew, Gregory N.